Aileron Therapeutics, Inc.

Income Statement

DEC '22 DEC '21 DEC '20 DEC '19 DEC '18 DEC '17 DEC '16 DEC '15 DEC '14 DEC '13
Sales 0 0 0 0 0 0 0 0 0 22.35
Sales Growth % - - - - - - - - -100 -
Cost of Goods Sold - - - - - - - - - -
COGS exclude D&A - - - - - - - - - -
Depreciation & Amortization 0.17 0.12 34 0.16 0.16 0.22 0.13 0.23 0.33 0.59 0.77
Gross Income - - - - - - - - - -
Gross Income Growth % - - - - - - - - - -
Gross Margin % - - - - - - - - - -
SG&A Expense 27.65 26.61 20.50 29.96 31.90 23.01 18.17 12.89 16.03 19.07
R&D Expense 17.97 17.01 11.17 17.66 18.45 14.24 10.28 7.83 9.33 12.23
Other Operating Expense 9.68 9.60 9.33 12.29 13.45 8.77 7.89 5.06 6.70 6.84
Stock Based Compensation 2.08 2.26 1.89 2.12 3.28 1.75 0.69 0.63 - -
EBIT -27.65 -26.61 -20.50 -29.96 -31.90 -23.01 -18.17 -12.89 -16.03 3.28
EBIT Growth % 3.92 29.78 -31.58 -6.08 38.64 26.64 40.96 -19.59 -588.72 -
EBIT Margin % - - - - - - - - - 14.68
Pretax Income -27.33 -26.16 -21.16 -29.37 -31.55 -22.60 -18.12 -12.88 -16.02 3.29
Pretax Income Growth % 4.45 23.65 -27.95 -6.91 39.60 24.72 40.68 -19.60 -586.93 -
Income Taxes 0 0 0 0 0 0 0 - - -
Income Tax Rate % - - - - - - - - - -
Net Income -27.33 -26.16 15 -21.16 -29.37 -31.55 -22.65 -18.20 -12.95 -16.07 0.19
Net Income Growth % 4.45 23.65 -27.95 -6.91 39.29 24.45 40.54 -19.42 -8557.89 -
Net Income Margin % - - - - - - - - - 0.85
Per Share - - - - - - - - - -
EPS (recurring) -6.02 -5.89 - - - - - - - -
EPS (diluted) -6.02 -5.89 - - - - - - - -
Basic Shares Outstanding 4.54 4.44 - - - - - - - -
Diluted Shares Outstanding 4.54 4.44 - - - - - - - -
MAR '23 DEC '22 SEP '22 JUN '22 MAR '22 DEC '21 SEP '21 JUN '21 MAR '21 DEC '20 SEP '20 JUN '20 MAR '20 DEC '19 SEP '19 JUN '19 MAR '19 DEC '18 SEP '18 JUN '18 MAR '18 DEC '17 SEP '17 JUN '17 MAR '17 DEC '16 SEP '16 JUN '16 MAR '16 DEC '15 SEP '15
Sales 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales Growth % - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Cost of Goods Sold - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
COGS exclude D&A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Depreciation & Amortization 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0 0.01 0.01 0.07 0.07 0.08 0.02 0.03 0.03 0.05 0.09 0.03 0.05 0.04 0.04 0.03 0.02 0.04 0.06 0.06 0.07 0.07 0.09
Gross Income - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Income Growth % - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Margin % - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
SG&A Expense 2.18 2.30 2.24 2.61 2.53 2.25 2.51 2.16 2.67 2.27 2.34 1.91 2.81 2.64 3.44 3.08 3.14 3.02 3.18 4.34 2.92 2.73 2.60 1.79 1.65 1.36 1.63 3.46 1.45 1.29 1.43
R&D Expense 1.81 2.40 4.24 5.43 5.89 4.56 4.28 3.85 4.32 1.93 2.68 2.49 4.07 4.71 4.48 4.30 4.17 3.96 4.32 5.32 4.85 4.31 3.83 3.16 2.94 3.09 2.61 2.09 2.49 2.02 1.78
Other Operating Expense 3.99 4.70 6.48 8.04 8.42 6.82 6.79 6.01 6.99 4.19 5.03 4.40 6.88 7.35 7.92 7.38 7.31 6.98 7.50 9.66 7.76 7.04 6.43 4.95 4.59 4.45 4.23 5.55 3.94 3.31 3.20
Stock Based Compensation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBIT -3.99 -4.70 -6.48 -8.04 -8.42 -6.82 -6.79 -6.01 -6.99 -4.19 -5.03 -4.40 -6.88 -7.35 -7.92 -7.38 -7.31 -6.98 -7.50 -9.66 -7.76 -7.04 -6.43 -4.95 -4.59 -4.45 -4.23 -5.55 -3.94 -3.31 -3.20
EBIT Growth % -52.63 -31 -4.55 33.82 20.47 62.67 35.01 36.57 1.60 -42.99 -36.49 -40.38 -5.88 5.30 5.60 -23.60 -5.80 -0.85 16.64 95.15 69.06 58.20 52.01 -10.81 16.50 34.44 32.19 - - - -
EBIT Margin % - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Pretax Income -4.78 -4.55 -6.37 -7.99 -8.42 -6.80 -6.70 -5.69 -6.98 -5 -5.02 -4.39 -6.75 -7.24 -7.75 -7.17 -7.21 -7.03 -7.43 -9.49 -7.59 -6.87 -6.26 -4.92 -4.56 -4.44 -4.22 -5.53 -3.93 -3.31 -3.20
Pretax Income Growth % -43.26 -33.12 -5.01 40.56 20.66 35.98 33.55 29.52 3.41 -30.94 -35.23 -38.77 -6.38 2.99 4.31 -24.45 -5.01 2.33 18.69 92.89 66.45 54.73 48.34 -11.03 16.03 34.14 31.87 - - - -
Income Taxes - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Income Tax Rate % - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income -4.78 -4.55 15 -6.37 -7.99 -8.42 -6.80 -6.70 -5.69 -6.98 -5 -5.02 -4.39 -6.75 -7.24 -7.75 -7.17 -7.21 -7.03 -7.43 -9.49 -7.59 -6.87 -6.26 -4.94 -4.58 -4.46 -4.24 -5.55 -3.94 -3.33 -3.22
Net Income Growth % -43.26 -33.12 -5.01 40.56 20.66 35.98 33.55 29.52 3.41 -30.94 -35.23 -38.77 -6.38 2.99 4.31 -24.45 -5.01 2.33 18.69 92.11 65.72 54.04 47.64 -10.99 16.24 33.93 31.68 - - - -
Net Income Margin % - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Per Share - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EPS (recurring) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EPS (diluted) -1.05 -1.00 -1.40 -1.76 -1.86 -1.50 -1.48 -0.06 -0.08 -0.12 -0.13 -0.14 -0.24 -0.26 -0.28 -0.26 -0.49 -0.48 -0.50 -0.64 -0.52 -0.47 -0.43 -0.34 -0.31 -0.30 -0.29 -0.38 -0.27 -0.23 -0.22
Basic Shares Outstanding - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Diluted Shares Outstanding 4.54 4.54 4.54 4.54 4.53 4.53 4.53 90.46 83.38 41.04 39.32 31.22 27.81 27.85 27.81 27.53 14.82 14.75 14.74 14.74 14.73 14.72 14.72 14.71 14.71 14.71 14.71 14.71 14.71 14.71 14.71
DEC '22 DEC '21 DEC '20 DEC '19 DEC '18 DEC '17
Sales 0.0 0.0 0.0 0.0 0.0 0.0
Sales Growth % - - - - - -
Cost of Goods Sold including D&A 0.169 0.121 0.163 0.155 0.218 0.129